REGENEREX, LLC

Company Information
Address 201 E JEFFERSON ST
LOUISVILLE, KY, 40202-


Information

DUNS: 140644969

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Delayed Tolerance Induction in Living Related Donor Renal Transplant Recipients

    Amount: $299,662.00

    DESCRIPTION (provided by applicant): We have developed a protocol that reproducibly induces transplantation tolerance in individuals undergoing a living related donor kidney transplant. Three subjects ...

    STTRPhase I2012Department of Health and Human Services
  2. Induction of Donor Tolerance in Renal Transplants

    Amount: $3,600,135.00

    DESCRIPTION: Renal transplantation is the preferred therapeutic approach for end organ failure. However, the chronic use of immunosuppressive agents is critical to prevent rejection. The drugs are cos ...

    STTRPhase II2011Department of Health and Human Services
  3. Stem Cell Graft Engineering to Treat Sickle Cell Disease

    Amount: $1,414,980.00

    DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is a genetic abnormality of red blood cells (RBC) that affects over 70,000 people in the United States, or approximately 1 in every 500 A ...

    STTRPhase II2008Department of Health and Human Services
  4. Induction of Donor Tolerance in Renal Transplants

    Amount: $447,862.00

    DESCRIPTION (provided by applicant): Bone marrow transplantation (BMT) can treat sickle cell anemia, type 1 diabetes, multiple sclerosis and other autoimmune disorders, and induces immune tolerance in ...

    STTRPhase I2005Department of Health and Human Services
  5. AMD-FCRx to Restore Damaged Pigment Epithelium

    Amount: $355,139.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. The hallmark of the disease is retinal pigment epithelial (RPE) dysf ...

    STTRPhase I2005Department of Health and Human Services
  6. Stem Cell Graft Engineering to Treat Sickle Cell Disease

    Amount: $220,500.00

    DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is an abnormality of red blood cells (RBC) that affects approximately 72,000 people in the United States, or approximately 1 in every 500 ...

    STTRPhase I2004Department of Health and Human Services
  7. Stem Cell Graft Engineering to Treat Sickle Cell Disease

    Amount: $220,500.00

    DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is an abnormality of red blood cells (RBC) that affects approximately 72,000 people in the United States, or approximately 1 in every 500 ...

    SBIRPhase IDepartment of Health and Human Services
  8. Induction of Donor Tolerance in Renal Transplants

    Amount: $447,862.00

    DESCRIPTION (provided by applicant): Bone marrow transplantation (BMT) can treat sickle cell anemia, type 1 diabetes, multiple sclerosis and other autoimmune disorders, and induces immune tolerance in ...

    SBIRPhase IDepartment of Health and Human Services
  9. AMD-FCRx to Restore Damaged Pigment Epithelium

    Amount: $355,139.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. The hallmark of the disease is retinal pigment epithelial (RPE) dysf ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government